What's in VistaGen Therapeutics, Inc.'s pipeline?

VistaGen Therapeutics, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with VistaGen Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Ajou University School of Medicine, Alameda Health System, American University of Beirut Medical Center, Asker & Baerum Hospital, AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/vistagen-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

VistaGen Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VistaGen Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fasedienol Nasal Spray	Fasedienol Nasal Spray	phase 3	NMDA receptor antagonist	NMDA receptor	Psychiatry / Neurology

Therapeutic area mix

Psychiatry / Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ajou University School of Medicine · 1 shared drug class
Alameda Health System · 1 shared drug class
American University of Beirut Medical Center · 1 shared drug class
Asker & Baerum Hospital · 1 shared drug class
AstraZeneca · 1 shared drug class
Auris Medical AG · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Acacia Pharma Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for VistaGen Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). VistaGen Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vistagen-therapeutics-inc. Accessed 2026-05-16.